GSK

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• GSK | 10/2/26 (öffnet in neuem Tab)

  ktnv.com · 02.10.2026

• Voting rights update pressures GSK stock near GBX1,847 resistance (öffnet in neuem Tab)

  Traders Union · 02.10.2026

• The Technical Signals Behind (GSK) That Institutions Follow (öffnet in neuem Tab)

  Stock Traders Daily · 01.10.2026

• Kristian Jensen: Begining a New Chapter at GSK After Novartis Journey (öffnet in neuem Tab)

  Oncodaily · 01.10.2026

• GSK (GSK) reports 4.05B voting rights, with 271M shares held in treasury (öffnet in neuem Tab)

  Stock Titan · 01.10.2026

• GSK adds liver candidate from Wave RNA partnership (öffnet in neuem Tab)

  European Biotechnology Magazine · 01.10.2026

• What's behind GSK's latest 1.8% stock pullback? (öffnet in neuem Tab)

  Traders Union · 01.10.2026

• GSK Updates Market on Total Voting Rights and Share Capital (öffnet in neuem Tab)

  TipRanks · 01.10.2026

• 
  Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks (öffnet in neuem Tab)

  Simply Wall St. · 01.10.2026

• GSK plc : JP Morgan reiterates its Sell rating (öffnet in neuem Tab)

  marketscreener.com · 01.10.2026

• Tyler Reynolds Joins GSK as Director, Digital Medicine (öffnet in neuem Tab)

  BioBuzz · 01.10.2026

• Why Did Haleon (LSE:HLN) Draw Attention As GSK Completed Its Exit This Week? (öffnet in neuem Tab)

  kalkinemedia.com · 01.10.2026

• How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate? (öffnet in neuem Tab)

  kalkinemedia.com · 01.10.2026

• Wave lands USD 12m as GSK advances SpiNA siRNA program (öffnet in neuem Tab)

  AllSci · 01.10.2026

• Why is GSK stock down today? Selloff intensifies, key levels to watch (öffnet in neuem Tab)

  Traders Union · 01.10.2026

• GSK (LSE:GSK) Expands TB Research as Gates Funding Continues (öffnet in neuem Tab)

  kalkinemedia.com · 01.10.2026

• GSK Pharma stock enters a results blackout before Q2 FY27 (öffnet in neuem Tab)

  ad-hoc-news.de · 01.10.2026

• Wave Life announces GSK’s selection of siRNA program to transition to GSK (öffnet in neuem Tab)

  TipRanks · 01.10.2026

• GSK (LSE:GSK) Gets Extended Gates Funding For Tuberculosis Drug Research (öffnet in neuem Tab)

  Simply Wall Street · 01.10.2026

• GSK continues to stock up on Wave's RNA drugs with liver-focused program (öffnet in neuem Tab)

  Fierce Biotech · 30.09.2026

• Does GSK (LSE:GSK) Have Fresh Momentum As London Pharma Gets A Lift From Cancer Dealmaking With FTSE 100 In Focus? (öffnet in neuem Tab)

  Kalkine Media · 30.09.2026

• GSK selects Wave Life Sciences hepatology candidate By Investing.com (öffnet in neuem Tab)

  Investing.com UK · 30.09.2026

• Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development (öffnet in neuem Tab)

  Yahoo Finance · 30.09.2026

• GSK (LSE:GSK) The Latest Update Raises A Bigger Question (öffnet in neuem Tab)

  30.09.2026

• Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies (öffnet in neuem Tab)

  30.09.2026

• Can GSK shares outperform FTSE 100 index over the long run? (öffnet in neuem Tab)

  Interactive Investor · 30.09.2026

• Spotlight On: GSK's HBV hopeful tops FDA's October agenda (öffnet in neuem Tab)

  FirstWord Pharma · 29.09.2026

• Re-entering the Dragon: GSK returns to China after 12 years in blood cancer drug push (öffnet in neuem Tab)

  This is Money · 29.09.2026

• GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated (öffnet in neuem Tab)

  Proactive financial news · 29.09.2026

• GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential? (öffnet in neuem Tab)

  29.09.2026